1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
HRS-4642 in Combination With Nimotuzumab and Chemotherapy for BRPC With KRAS G12D MutationBorderline Resectable Pancreatic AdenocarcinomaRecruitingPhase 22026-02-13NCT07240766